Quote:
small n
different populations (M/F, Age, Race, Comorbidities)
no standardization of variables
different collection dates (unvaxed over 9 months, Vaxed over 3 months)
no controls over hospital procedures
limiting analysis to 180 days (surprisingly inline with the recommended booster shot)
should i continue?
So while we are play-acting,
- 7,000 data points is not small n
- If you read the footnotes you will see that the results were controlled for everything you mentioned:
"Odds ratios were adjusted for age, geographic region, calendar time (days since January 1, 2021), and local virus circulation (percentage of SARS-CoV-2 positive results from testing within the counties surrounding the facility on the date of the hospitalization) and balanced using inverse weights on characteristics that differed between the two groups (calculated separately for each odds ratio model) using facility characteristics, sociodemographic characteristics, and underlying medical conditions."
- What do you mean by lack of standardization in variables?
- He also controlled for different collection dates
"Three secondary analyses were also conducted. First, the impact of whether and how the time interval since previous infection or full vaccination was adjusted was examined. Specifically, any time since either previous infection or completion of vaccination was considered. Then, previously infected patients were limited to those with more recent infections (i.e., 90225 days before hospitalization [the lowest two tertiles of number of days since infection]), and fully vaccinated patients were limited to those with the longest interval since completion of vaccination (i.e., receipt of second mRNA vaccine dose 45213 days before hospitalization [the highest two tertiles of number of days since vaccination]). Then, number of days since previous infection or completion of vaccination, rather than calendar time, was adjusted in the model."
- "no controls over hospital procedures" - Fair point and the author specifically cites this as a potential shortcoming.
Do you really think you have one-upped leading medical researchers in terms of stuff like this?